Posted by Gary Schwitzer in Disease mongering, Drug industry, Health care costs, Health care journalism, Imaging issues
The New Yorker profile of Dr. Oz, “The Operator: Is the most trusted doctor in America doing more harm than good?”
The NPR piece, “Hanging A Price Tag On Radiology Tests Didn’t Change Doctors’ Habits.”
PharmedOut.org’s new Drug Ads teaching tool. It’s a three-part slideshow covering misleading advertising in medical journals, indirect marketing, and disease-mongering; an overview of FDA guidelines for advertising exemplified by numerous warning letters; and a typical timeline of promotion for new prescription drugs and patent extension strategies.
Follow us on Facebook, and on Twitter:
Comments are closed.
Better than a competing piece by Reuters but still a little short on some details about this asthma drug study.
An adequate summary of this asthma drug trial’s design doesn’t make up for the overly optimistic tone about the drug’s future. A New York Times story was better.
This story focuses on a family that may have a rare genetic mutation that increases their risk of heart disease. Unfortunately, the “rare” part wasn’t mentioned until 1,600 words into this 2,100 word story.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2013 Health News Review
